C-reactive protein: Linking inflammation to cardiovascular complications

Circulation

Volumn 104, Issue 9, 2001, Pages 974-975

  Yeh, Edward T H ^a,b,c   Anderson, H Vernon ^b,c   Pasceri, Vincenzo ^c   Willerson, James T ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Angioplasty; Editorials; Inflammation

Indexed keywords

C REACTIVE PROTEIN;

ANGIOPLASTY; ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; COMPLEMENT ACTIVATION; DISEASE SEVERITY; EDITORIAL; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; INFLAMMATION; MONOCYTE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR;

EID: 0035964324     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.9.974     Document Type: Editorial

References (21)

1. 27th Bethesda Conference: Matching tine intensity of risk factor management with tine hazard for coronary disease events: Task Force 1: Pathogenesis of coronary disease: The biologic role of risk factors
2. Atherosclerosis: An inflammatory disease
3. Molecular bases of the acute coronary syndromes
4. VCAM-1 is critical in atherosclerosis
5. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction
6. Elevation of C-reactive protein in "active" coronary artery disease
7. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
8. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
9. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
10. Serological reactions in pneumonia with a non-protein somatic fraction of pneumonococcus
11. Function of C-reactive protein
12. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
13. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas
14. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
15. Direct proinflammatory effect of C-reactive protein on human endothelial cells
16. Modulation of c-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs
17. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: Relationship with age, sex, and hormone replacement treatment
18. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) Investigators
19. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators
20. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention